trimethoprim, sulfadoxine drug combination has been researched along with Escherichia coli Infections in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheong, HJ; Cho, YK; Choi, TY; Chung, MH; Kang, JO; Ki, M; Kim, J; Kim, SJ; Kim, Y; Kwon, KT; Lee, H; Lee, JS; Lim, SK; Pai, H; Park, DW; Ryu, SY; Seo, MR; Wie, SH | 1 |
| Heilberg, IP; Medina-Pestana, JO; Rocha, LA; Siliano, PR | 1 |
| Beerepoot, MA; de Borgie, CA; de Reijke, TM; Geerlings, SE; Koeijers, J; Nys, S; Prins, JM; Stobberingh, E; ter Riet, G; van der Wal, WM; Verbon, A | 1 |
| Bengtsson, B; Franklin, A; Greko, C; Jacobsson, SO; Luthman, J; Wiese, B | 1 |
1 trial(s) available for trimethoprim, sulfadoxine drug combination and Escherichia coli Infections
| Article | Year |
|---|---|
Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Double-Blind Method; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Lactobacillus; Middle Aged; Postmenopause; Sulfadoxine; Treatment Outcome; Trimethoprim; Urinary Tract Infections; Urine | 2012 |
3 other study(ies) available for trimethoprim, sulfadoxine drug combination and Escherichia coli Infections
| Article | Year |
|---|---|
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea.
Topics: Anti-Bacterial Agents; Cefepime; Cell Survival; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Nitrofurantoin; Penicillins; Republic of Korea; Sulfadoxine; Treatment Outcome; Trimethoprim; Urinary Tract Infections | 2014 |
The role of host factors and bacterial virulence genes in the development of pyelonephritis caused by Escherichia coli in renal transplant recipients.
Topics: Adhesins, Escherichia coli; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Brazil; Chi-Square Distribution; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fimbriae Proteins; Humans; Hydroxamic Acids; Kidney Transplantation; Logistic Models; Male; Middle Aged; Odds Ratio; Porins; Prospective Studies; Pyelonephritis; Risk Assessment; Risk Factors; Sex Factors; Sulfadoxine; Trimethoprim; Virulence; Virulence Factors; Young Adult | 2010 |
Efficacy of trimethoprim-sulfadoxine against Escherichia coli in a tissue cage model in calves.
Topics: Animals; Area Under Curve; Cattle; Chromatography, High Pressure Liquid; Drug Combinations; Escherichia coli Infections; Half-Life; Metabolic Clearance Rate; Microbial Sensitivity Tests; Sulfadoxine; Thymidine; Trimethoprim | 2002 |